Systematic review / meta-analysis / 2020
Psyllium consumption significantly reduced triglycerides, LDL cholesterol, fasting blood sugar, and HbA1c in patients with diabetes.
A systematic review and meta-analysis of eight randomized controlled trials evaluated the effects of psyllium in 395 diabetic participants. Psyllium consumption led to significant reductions in triglycerides (WMD: -19.18 mg/dl, 95% CI [-31.76, -6.60]), low-density lipoprotein (WMD: -8.96 mg/dl, 95% CI [-13.39, -4.52]), fasting blood sugar (WMD: -31.71 ml/dl, 95% CI [-50.04, -13.38]), and hemoglobin A1c (WMD: -0.91%, 95% CI [-1.31, -0.51]). There were no significant changes in high-density lipoprotein, body mass index, cholesterol, or weight.
- Study type
- Systematic review and dose-response meta-analysis of RCTs
- Who was studied
- 395 diabetic participants across 8 studies (9 arms)
- What was measured
- Weight, BMI, lipid profiles (TG, LDL, HDL, total cholesterol), and glucose metabolism (FBS, HbA1c)
THE PAPER
The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: A systematic review and dose-response meta-analysis of randomized controlled trials.
Xiao Z, Chen H, Zhang Y, Deng H, Wang K, Bhagavathula AS, Almuhairi SJ, Ryan PM, Rahmani J, Dang M, Kontogiannis V, Vick A, Wei Y. Phytother Res, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.